To Set New Benchmarks in Global Healthcare

To become one of top 20 global players for innovative products, including the small volume of parenteral and lyophilized injections and eye-care products.

  • Proton pump inhibitors
  • Antimalarial
  • Anti-inflammatory
  • Anesthetics including protocol
  • Ophthalmic
  • Anti-infective
  • Antifungal

  • Ciron to have
    2 of the top 10 brands in derma segment.
    To invest in R&D and develop new products as per our mission.
    To start the API division by March 2018.
    File at least 20 ANDA's / Dossiers in USA, EU, Australia, and other regulated markets.
    © Cirondrugs, all rights reserved.